Same Indication

Enasidenib Mesylate vs Methotrexate

## Enasidenib Mesylate vs Methotrexate: Overview

This comparison examines the pharmacological differences between **Enasidenib Mesylate** and **Methotrexate**.

## Mechanism of Action

**Methotrexate**: Dihydrofolate reductase inhibitor.

## Pharmacokinetics

**Half-life**: Enasidenib Mesylate — N/A; Methotrexate — 3-10 hours.

## Chemical Properties

**Molecular Formula**: Enasidenib Mesylate — N/A; Methotrexate — C20H22N8O5.

**Molecular Weight**: Enasidenib Mesylate — N/A; Methotrexate — 454.4400 g/mol.

**Type**: Enasidenib Mesylate — Small molecule; Methotrexate — Small molecule.